プロモーションスケジュール Aadi Bioscience, Inc.
詳細なスケジュール
簡易グラフ
会社について
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
| Цена ао |
2.2 |
| Выручка |
0.000749 |
| EBITDA |
-0.0225 |
| Число акций ао |
0.02692 млрд |
| P/S |
34.68 |
| P/BV |
0.711 |
| EV/EBITDA |
0.55 |
| ISIN |
US00032Q1040 |
| Сайт |
https://aadibio.com
|
| Валюта |
usd |
| IPO date |
2017-08-08 |
| Sector |
Health Care |
| Industry |
Biotechnology |
| Валюта отчета |
usd |
| 1日あたりの価格変動: |
0% (2.13) |
| 週ごとの価格変動: |
+7.04% (1.99) |
| 月ごとの料金変更: |
+18.33% (1.8) |
| 3ヶ月間の価格変動: |
+39.22% (1.53) |
| 半年間の価格変動: |
+15.76% (1.84) |
| 年間の価格変動: |
-46.62% (3.99) |
| 3年間の価格推移: |
-92.29% (27.63) |
| 5年間の価格推移: |
+204.29% (0.7) |
| 年初からの価格変動: |
-55.16% (4.75) |
|
|
過小評価
| 名前 |
意味 |
学年 |
| P/S |
2.18 |
7 |
| P/BV |
0.5041 |
10 |
| P/E |
0 |
0 |
| EV/EBITDA |
0.0395 |
10 |
| 合計: |
|
5.88 |
|
効率
| 名前 |
意味 |
学年 |
| ROA, % |
-49.66 |
0 |
| ROE, % |
-62.52 |
0 |
| 合計: |
|
0 |
|
|
|
配当金
| 名前 |
意味 |
学年 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 合計: |
|
0 |
|
義務
| 名前 |
意味 |
学年 |
| Debt/EBITDA |
-0.0979 |
10 |
| 合計: |
|
9.8 |
|
成長の衝動
| 名前 |
意味 |
学年 |
| 収益性 Revenue, % |
3151.54 |
10 |
| 収益性 Ebitda, % |
209.33 |
10 |
| 収益性 EPS, % |
118.14 |
10 |
| 合計: |
|
10 |
|
| スーパーバイザー |
役職 |
支払い |
生年 |
| Dr. Neil P. Desai Ph.D. |
Founder & Executive Chairman |
710.35k |
1965 (59 年) |
| Dr. Loretta M. Itri F.A.C.P., M.D. |
Chief Medical Officer |
617.45k |
1950 (74 年) |
| Mr. David J. Lennon Ph.D. |
President, CEO & Director |
277.75k |
1971 (53 年) |
| Mr. Scott M. Giacobello CPA |
CFO, Treasurer, Investor Relations & Corporate Communications |
643.23k |
1970 (54 年) |
| Mr. Stephen M. Rodin J.D. |
Senior VP of Legal & General Counsel |
N/A |
1976 (48 年) |
| Mr. Raymond G. Steitz |
Senior VP of Human Resources & Chief Human Resources Officer |
N/A |
1959 (65 年) |
| Mr. Bryan Ball |
Chief Technical Operations Officer |
N/A |
1970 (54 年) |
